Oracle provides the world’s most complete, open, and integrated business software and hardware systems, with more than 370,000 customers— including 100 of the Fortune 100— representing a variety of sizes and industries in more than 145 countries around the globe.

23andMe is a retail DNA testing service providing information and tools for consumers to learn about and explore their DNA. They utilize the Illumina OmniExpress Plus Research Use Only Chip which has been customized for use in all of our products and services by 23andMe.

AACR Foundation supports that of the AACR - to prevent and cure cancer through research, education, communication and collaboration. Through its programs and services, the AACR fosters cancer research and related biomedical science; accelerates the dissemination of new research findings among scientists and others dedicated to the conquest of cancer; promotes science education and training; and advances the understanding of cancer causes, prevention, diagnosis and treatment throughout the world.

Addario Lung Cancer Medical Institute (ALCMI) is dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for Lung Cancer patients.

Agilent Technologies is a leading supplier of life science instrumentation and reagents. Together with Stratagene and Automation Solutions, Agilent provides complete solutions, from sample preparation through data analysis, providing suites of products for multiple genomic applications, including gene expression, CNV/CGH, target enrichment, QPCR/PCR, RNA/DNA quality control and all associated instrumentation.

Accelerated Medical Diagnostics (AMD) is developing the PlatinDx assay, which provides direct measurement of in vivo tumor responses to a microdose (~1/100th the therapeutic dose) of platinum-based chemotherapy agents such as carboplatin and oxaliplatin, allowing selection of the correct therapy for each patient thus saving suffering and costs on unneeded therapy.

Analytics Plus is singularly focused on helping companies monetize their large investments in data infrastructure and translate data into business solutions. The healthcare solutions in this space are comprehensive and range from analytics that support promotion and adoption of prescription drugs by a larger groups of providers to measuring the effectiveness of sales force and creating databases that provide competitive intelligence in the prescription drug marketplace.

Atossa Genetics, Inc. helps women maintain health and well being through innovative products and services to help prevent, diagnose, and treat breast cancer. We are a healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer.

Aragen Bioscience is a contract research and development organization in Morgan Hill, California. Aragen specializes in recombinant cell line and hybridoma development, cell culture and protein purification process development and protein production, primary and immortalized cell-based assays, in vivo models of human disease and custom immunological services.

BayBio is Northern California's life science association, bringing the world's greatest life science community to your fingertips. With the support of more than 450 member organizations, BayBio is delivering the next generation association to you today.

Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. Our diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs. .

BGI has a proven track record of innovative, high-profile research that has been published in over 130 top tier academic journals such as Nature and Science. Our goal is to make leading-edge genomics highly accessible to the global research community through our investment in infrastructure that leverages the industry’s best technology, economies of scale and expert bioinformatics resources. This enables and empowers researchers to quickly migrate from data to discovery. 

BioCentury mission is to provide value-added information and analysis for biotech and pharma companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of biopharmaceutical ventures. Our breadth of coverage includes corporate strategy, partnering, emerging technology, clinical data, public policy and the financing markets.

Bioneer aims to to become a leading supplier in the field of oligonucleotide-based therapeutics, diagnostics and drug development by applying its core competencies in molecular biology, DNA/RNA synthesis chemistry, process development and instrument technology. As a leading Biotech company, Bioneer will provide the finest value-priced products for the global healthcare market by application of state-of-art technologies bringing life-saving treatments as well as diagnostics to the largest numbers of people.

Biotech Vendor Service (BVS) provides effective and efficient vendor management for bio-tech, pharmaceutical and academic research and procurement departments. This is accomplished through the expert BVS staff, backed by an ever-expanding network of top-tier suppliers. A powerful combination that has resulted in exponential growth in the number of events delivered across the US. In the first 18 months of operation, BVS delivered over 230 vendor product shows, technical seminars and special events.

Caprion Proteomics leading and proprietary proteomics discovery technologies - CellCarta® - enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly reduce risk and enhance clinical development productivity and decision making in pharmaceutical research.

Deloitte and its subsidiaries have 45,000 professionals in the U.S. with a single focus: serving our clients and helping them solve their toughest problems. We work in four key business areas — audit, financial advisory, tax and consulting — but our real strength comes from combining the talents of those groups to address clients’ needs.

Fenwick & West is a national law firm that provides comprehensive legal services to technology and life sciences clients of national and international prominence. They have offices in Silicon Valley, San Francisco, Seattle and Boise.

FortressLinQ exciting mobile interactive technologies improve the Health Care experience through better informed decision making, Patient/Provider collaboration, and unique revenue generation opportunities that help patients monetize their Health Funding Accounts and create new profit streams for physicians; enabling both the Provider and the Patient an open exchange and marketplace that affords each the ability to better manage and afford their respective decisions and costs of providing and acquiring health care.

Genomic Health is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services.

INRange Systems, Inc. aims to insure that a patient takes the right pill at the right time as directed by their physician. Outpatient medication adherence rates average between 40% and 50% and cost the healthcare system more than $290 Billion per year (New England Journal of Commerce).

Medivo is focused on bringing personalized medicine into practice in the areas of preventive and therapeutic care. Personalized medicine is a more patient-focused approach combining health IT and genetic and lab testing driving the future of quality care and improving individual outcomes. Medivo provides educational, engagement and clinical services to patients and physicians over the Medivo Platform.

Nixon Peabody has approximately 700 attorneys collaborating across major practice areas across the U.S. and in European and Asian commercial centers, the firm’s size, diversity, and advanced technological resources enable it to offer comprehensive legal services to individuals and organizations of all sizes in local, state, national, and international matters. Our clients range from Fortune 50 corporations to global banking and finance institutions, name-brand retailers, emerging entrepreneurs, and world-class research institutions.

Nodality is a biotechnology company focused on developing highly predictive tests to enable biologically-informed clinical treatment decisions in patients with cancer and autoimmune disease. The company's proprietary technology, Single Cell Network Profiling (SCNP), was developed in the laboratory of Professor Garry Nolan and licensed from Stanford University.

Patient Power is devoted to helping you and your family through knowledge, to get the best medicine and return to good health. It is built on a library of programs, which continues to grow with the addition of each week's new webcasts. These programs feature top medical experts and inspiring patients from some of America's leading medical institutions.

Roche Applied Science provides complete solutions for genomic analysis. Analyze sequence changes, study copy number variations, identify SNPs/genotype, and more with a broad variety of instruments, reagents, and software that includes the new, benchtop GS Junior Sequencing System, the proven Genome Sequencer FLX System, NimbleGen microarrays and sequence capture oligo pools, the LightCycler® 480 Real-Time PCR System, and MagNA Pure 96 System for nucleic acid purification.

SureGene LLC utilizes modern genetic technology to discover the underlying genetic basis for psychiatric diseases and drug response. They develop genetic discoveries into products (molecular diagnostic tests) used to improve the care of people with serious mental illness. They are currently developing a genetic test that will be useful in predicting whether antipsychotic drugs are likely to be safe and effective for particular patients.

Sanovas Surgical Technologies significantly advances minimally invasive surgery through advanced visualization and physiologic measurement systems that operate within new sensory guided interventional catheters to provide innovative navigation, treatment, resection and the point specific delivery and application of drug and immune therapies; creating an innovative new solution that is poised to become the standard of care in the Interventional Pulmonary Science.